Multiparameter scoring system for the prognosis of differentiated thyroid cancer
暂无分享,去创建一个
H. Ackermann | F. Grünwald | C. Menzel | N. Döbert | K. Zaplatnikov | M. Abeln | M. Welsch
[1] Tae Yong Kim,et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. , 2005, The Journal of clinical endocrinology and metabolism.
[2] A. Al-nahhas. Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals , 2004, Nuclear medicine communications.
[3] O. Schober,et al. Overtherapy or undertherapy for papillary thyroid microcarcinoma? Therapeutic considerations for radioiodine ablation , 2004 .
[4] J. Wu,et al. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. , 2004, Thyroid : official journal of the American Thyroid Association.
[5] A. Miyauchi,et al. Encapsulated Anaplastic Thyroid Carcinoma Without Invasive Phenotype with Favorable Prognosis: Report of a Case , 2003, Surgery Today.
[6] C. Hsueh,et al. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas , 2002, Journal of surgical oncology.
[7] I. Fleming,et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.
[8] H. Hundeshagen,et al. [Low-risk thyroid carcinoma--therapy, follow-up and prognosis]. , 1997, NuclearMedicine.
[9] R. Fimmers,et al. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] H. Evans. Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. , 1996, The American journal of surgical pathology.
[11] E. Germann,et al. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. , 1995, American journal of surgery.
[12] J. Hanke,et al. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]. , 1995, Nuklearmedizin. Nuclear medicine.
[13] R. Hruban,et al. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study , 1994, Cancer.
[14] E. Bergstralh,et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.
[15] B. Cady,et al. An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.
[16] W. Taylor,et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. , 1987, Surgery.
[17] M. van Glabbeke,et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.
[18] Daan Brandenbarg. The National. , 1892 .
[19] B. de Keizer,et al. Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. , 2005, European journal of endocrinology.